EVOK
Price
$2.72
Change
+$0.03 (+1.12%)
Updated
Jul 3 closing price
Capitalization
5.17M
PRFX
Price
$1.40
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
3.06M
40 days until earnings call
Interact to see
Advertisement

EVOK vs PRFX

Header iconEVOK vs PRFX Comparison
Open Charts EVOK vs PRFXBanner chart's image
Evoke Pharma
Price$2.72
Change+$0.03 (+1.12%)
Volume$25.03K
Capitalization5.17M
PainReform
Price$1.40
Change-$0.00 (-0.00%)
Volume$14.29K
Capitalization3.06M
EVOK vs PRFX Comparison Chart in %
Loading...
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVOK vs. PRFX commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVOK is a Hold and PRFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (EVOK: $2.72 vs. PRFX: $1.40)
Brand notoriety: EVOK and PRFX are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EVOK: 157% vs. PRFX: 6%
Market capitalization -- EVOK: $5.17M vs. PRFX: $3.06M
EVOK [@Pharmaceuticals: Other] is valued at $5.17M. PRFX’s [@Pharmaceuticals: Other] market capitalization is $3.06M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVOK’s FA Score shows that 0 FA rating(s) are green whilePRFX’s FA Score has 0 green FA rating(s).

  • EVOK’s FA Score: 0 green, 5 red.
  • PRFX’s FA Score: 0 green, 5 red.
According to our system of comparison, EVOK is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVOK’s TA Score shows that 4 TA indicator(s) are bullish while PRFX’s TA Score has 4 bullish TA indicator(s).

  • EVOK’s TA Score: 4 bullish, 6 bearish.
  • PRFX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PRFX is a better buy in the short-term than EVOK.

Price Growth

EVOK (@Pharmaceuticals: Other) experienced а +3.03% price change this week, while PRFX (@Pharmaceuticals: Other) price change was -3.45% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

EVOK is expected to report earnings on May 13, 2025.

PRFX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
EVOK($5.17M) has a higher market cap than PRFX($3.06M). EVOK YTD gains are higher at: -38.462 vs. PRFX (-58.271). EVOK has higher annual earnings (EBITDA): -7.29M vs. PRFX (-9.57M). PRFX has more cash in the bank: 8.03M vs. EVOK (4.74M). PRFX has less debt than EVOK: PRFX (86K) vs EVOK (5M). EVOK has higher revenues than PRFX: EVOK (5.18M) vs PRFX (0).
EVOKPRFXEVOK / PRFX
Capitalization5.17M3.06M169%
EBITDA-7.29M-9.57M76%
Gain YTD-38.462-58.27166%
P/E RatioN/A2.92-
Revenue5.18M0-
Total Cash4.74M8.03M59%
Total Debt5M86K5,814%
FUNDAMENTALS RATINGS
EVOK: Fundamental Ratings
EVOK
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
81
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EVOKPRFX
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend about 1 month ago
88%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PATH13.290.44
+3.42%
UiPath
THCH2.980.05
+1.88%
TH International Ltd
TNC81.98-0.33
-0.40%
Tennant Company
CERO9.26-0.20
-2.11%
CERO Therapeutics Holdings Inc
FC22.10-2.07
-8.56%
Franklin Covey Company

EVOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVOK has been loosely correlated with RDHL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EVOK jumps, then RDHL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVOK
1D Price
Change %
EVOK100%
+1.12%
RDHL - EVOK
33%
Loosely correlated
+1.50%
NBIX - EVOK
28%
Poorly correlated
-0.22%
EOLS - EVOK
26%
Poorly correlated
+0.65%
EVO - EVOK
24%
Poorly correlated
-3.23%
PRFX - EVOK
24%
Poorly correlated
N/A
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and EVOK have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and EVOK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
N/A
EVOK - PRFX
24%
Poorly correlated
+1.12%
AMRX - PRFX
24%
Poorly correlated
+0.60%
LFCR - PRFX
21%
Poorly correlated
N/A
AYURF - PRFX
21%
Poorly correlated
N/A
KMDA - PRFX
21%
Poorly correlated
+1.81%
More